September 1 2014 - ipopemasecurities.pl · DM BH Citi 7 2 5 10 1 ... IDM 9 8 13 13 6 DM Trigon 10...

14
1 September 2014

Transcript of September 1 2014 - ipopemasecurities.pl · DM BH Citi 7 2 5 10 1 ... IDM 9 8 13 13 6 DM Trigon 10...

1 September

2014

2

The IPOPEMA Group - an introduction

Sales & Trading Asset Management Investment Banking Business Advisory

IPOPEMA AM IPOPEMA BC IPOPEMA Securities

WSE equities

BSE equities

PSE equities

Bonds

Equity research

Public offerings (IPO, SPO)

M&A deals

Bond issues

Financial restructuring

Private equity financing

Asset management Strategic advisory

IT advisory

Funds

Closed-end funds

Mutual funds

Active management

funds

IPOPEMA TFI

IPOPEMA Securities is one of the leading providers of brokerage services to institutional clients on the Warsaw, Budapest and

Prague Stock Exchanges. Since June 2014 IPOPEMA has been a member of the Bucharest Stock Exchange.

IPOPEMA Securities boasts one of the largest and most active teams of Investment Bankers in Poland.

The IPOPEMA Brokerage Department carries out between 8-10% of daily volume on the WSE

The Equity Research Department analyses 60 companies listed on the WSE and BSE, including most of the blue-chip stocks

included in the WIG30 index.

IPOPEMA TFI, managing more than 90 funds, is amongst the most active closed-end fund management companies in Poland.

IPOPEMA TFI manages more than PLN 25 bn in assets, and is one of the largest fund management companies in Poland.

The IPOPEMA Business Consulting team comprises more than 40 professionals.

3

IPOPEMA - a leader on the Polish Capital Market

Professional team involved in:

IPO’s and secondary offerings,

M&A advisory,

bonds offerings,

financial restructuring,

Track record of more than 80 transactions

(total value over PLN 30bn).

• Vice-chairman of

IPOPEMA Securities S.A.

• Heads the

Capital Markets Department

• Previously worked for

BRE Corporate Finance Mariusz

Piskorski

IPOPEMA Capital Markets Department

- involved in most of the leading Polish Capital Markets deals of 2012-14

Best Capital Markets teams

(ranking 2011*)

Best Capital Markets teams

(ranking 2012***)

** Ranking prepared by Parkiet and Rzeczpospolita

by volume of IPOs conducted (PLN m)

*** Ranking prepared by Dealogic by volume

of transactions conducted (PLN m)

493

576

713

746

797

995

1196

1224

Citi

Credit Suisse

UniCredit

UBS

ING

JP Morgan

PKO BP

170

177

180

184

524

524

524

709

BESI

PKO BP

Trigon

Millenium

Barclays

Morgan Stanley

JP Morgan

* Ranking prepared by Parkiet and Rzeczpospolita

by volume of IPOs conducted (PLN m)

Best Capital Markets teams

(ranking 2012**)

2012

Best Capital

Markets team

565

767

767

767

845

845

905

1290

BZ WBK

Goldman Sachs

JP Morgan

Societe Generale

Citi Handlowy

PKO BP

UniCredit

The largest

number of IPOs in

2010-2011

The largest value

of IPO in 2012

2013

Polish Equity House

of the Year

2013

Best privatisation

IPO

2013

The best equity house

in Poland

4

IPOPEMA - a leader in Equity Sales and Trading

2012 Best Brokerage

House

2011 Best Brokerage

House

2013 Best Brokerage

House

Vice - Chairman of

IPOPEMA Securities S.A.

Heads the Ipopema

Sales-Trading Department

Previously :

- Board Member and Director of

Institutional Clients at Citi

- Head of Sales at ABN Amro

Arkadiusz joined IPOPEMA in August 2012

has over 15 years of experience, being among

the top brokers in Poland for several years

prior to joining IPOPEMA, he worked for Citibank

Voted no 2 Best broker in Poland by Forbes in

2013 and 2011, no 3 in 2012.

2011 Best broker

Arkadiusz Łabuńko

Stanisław Waczkowski

2012 Best broker

Top Ranking Sales Team and Traders

IPOPEMA market share in WSE trading (since 2013)

Equity Sales Department

Forbes – Polish Institutional Broker Survey 2013

2013 Best broker

Institution

Overall

Ranking

-2013

Profess

ionalism

Service

quality

Analysis

quality

Overall

Ranking

-2012

PKO BP 1 3 2 3 5

Erste 3 5 3 12 7

UniCredit CAIB 4 7 6 6 12

ING 5 4 4 9 5

mBank 6 9 9 1 3

DM BH Citi 7 2 5 10 1

Wood&Co 8 6 3 7 11

Espirito Santo 9 8 8 5 8

Trigon DM 10 11 7 11 14

DM BH Citi 13,07%

PKO BP 8,96%

8,14%

Credit Suisse 7,67%

BZ WBK 6,66% Wood&Co

5,19% mBank 4,38%

Deutsche Bank 4,19%

KBC 3,40%

ING 3,35%

Others 35,00%

5

0%

2%

4%

6%

8%

10%

12%

14%

0

1

2

3

4

5

6

Ja

n-1

0

Feb

-10

Mar-

10

Apr-

10

May-1

0

Ju

n-1

0

Ju

l-10

Aug

-10

Sep

-10

Oct-

10

No

v-1

0

De

c-1

0

Ja

n-1

1

Feb

-11

Mar-

11

Apr-

11

May-1

1

Ju

n-1

1

Ju

l-11

Aug

-11

Sep

-11

Oct-

11

No

v-1

1

De

c-1

1

Ja

n-1

2

Feb

-12

Mar-

12

Apr-

12

May-1

2

Ju

n-1

2

Ju

l-12

Aug

-12

Sep

-12

Oct-

12

No

v-1

2

De

c-1

2

Ja

n-1

3

Feb

-13

Mar-

13

Apr-

13

May-1

3

Ju

n-1

3

Ju

l-13

Aug

-13

Sep

-13

Oct-

13

No

v-1

3

De

c-1

3

Ja

n-1

4

Feb

-14

Mar-

14

Apr-

14

May-1

4

Ju

n-1

4

Ju

l-14

Aug

-14

BSE trading (EURbn) IPOPEMA's market share

IPOPEMA - significant market shares in Warsaw and Budapest

IPOPEMA’s market share of equity volume on the WSE (2009-2012) – between 8-10%

Source: WSE, IPOPEMA

IPOPEMA’s market share of equity volume on the WSE (2009-14) – between 6 and 11%

IPOPEMA’s market share of equity volume on the BSE (2010-14) – between 3 and 12%

0%

2%

4%

6%

8%

10%

12%

0

10

20

30

40

50

60

Ja

n-0

9

Feb

-09

Mar-

09

Apr-

09

May-0

9

Ju

n-0

9

Ju

l-09

Aug

-09

Sep

-09

Oct-

09

No

v-0

9

De

c-0

9

Ja

n-1

0

Feb

-10

Mar-

10

Apr-

10

May-1

0

Ju

n-1

0

Ju

l-10

Aug

-10

Sep

-10

Oct-

10

No

v-1

0

De

c-1

0

Ja

n-1

1

Feb

-11

Mar-

11

Apr-

11

May-1

1

Ju

n-1

1

Ju

l-11

Aug

-11

Sep

-11

Oct-

11

No

v-1

1

De

c-1

1

Ja

n-1

2

Feb

-12

Mar-

12

Apr-

12

May-1

2

Ju

n-1

2

Ju

l-12

Aug

-12

Sep

-12

Oct-

12

No

v-1

2

De

c-1

2

Ja

n-1

3

Feb

-13

Mar-

13

Apr-

13

May-1

3

Ju

n-1

3

Ju

l-13

Aug

-13

Sep

-13

Oct-

13

No

v-1

3

De

c-1

3

Ja

n-1

4

Feb

-14

Mar-

14

Apr-

14

May-1

4

Ju

n-1

4

Ju

l-14

Aug

-14

WSE trading (PLNbn) IPOPEMA's market share

6

Highly ranked Equity Research Department

Equity Research Department covers more than 60 companies

Piotr Zielonka i Iza Rokicka – the best Equity Analysts in Poland

Sector Selected Companies

Financial Alior, BZ WBK, Getin Noble Bank, Handlowy, ING BSK, mBank,

Millennium, Pekao, PKO BP, Kruk, Open Finance

Construction Budimex, Elektrobudowa, Erbud, Polimex-Mostostal, Trakcja, ZPUE

Metals & Mining LW Bogdanka, KGHM

Chemicals Ciech, Synthos

Agriculture Astarta, Kernel, IMC, KSG Agro, Ovostar

Real Estate Echo Investment, JWC, GTC, Polnord

Industrial

ACE, Gedeon Richter, Mennica Polska, PKP Cargo, Roverse, Ambra,

Amica, Aplisens, Boryszew, Delicacies, Famur, Krynicki Recykling, Libet,

Orzeł Biały, Stalexport Autostrady, Stomil Sanok, Śnieżka

Retail & Distribution CCC, Emperia, Eurocash, Gino Rossi, Inter Cars, Jeronimo Martins, LPP,

Monnari Trade, Wawel

Oil & Gas Lotos, PKN Orlen, PGNiG

Energy Enea, Energa, PGE, Tauron, ZE PAK

Highest quality of

Analysis and

Recommendations

2011

Highest quality of

Analysis and

Recommendations

2012

Highest quality of

Analysis and

Recommendations

2010

„Consistently the best Equity Research Department”

Equity Research ranking – 2012 Piotr Zielonka, CFA

• Since September 2013, Head of Equity Research

• Consistently ranked as the best equity analyst in Poland in ranking

prepared by the Forbes” magazine and Parkiet daily

• With over a decade of experience in the Capital Markets, Piotr

previously worked for Citi Handlowy and PZU Asset Management

The best

Market

Strategy

2012

Best analyst in 2014

Forbes i Parkiet

Best analyst in 2013

Forbes i Parkiet

Best construction

sector analyst

Best retail and

distribution sector

analyst

Best energy sector

analyst

The best

Market

Strategy

2013

Best analyst in 2012

Forbes i Parkiet

Most accurate

Recommendations

2013

Iza Rokicka

• Since February 2014, Deputy Head of Equity

Research

• Associated with Polish Capital Market for many years.

Iza previously worked as an Analyst for UniCredit and

DI BRE.

• Iza specializes in the analysis of companies from

financial sector. Recent years voted leading analyst in

that sector by Parkiet daily.

Bank Overall

ranking

(2012)

Offer

complexity

Professiona

lism

Report

quality

Report

usefulness

mBank 2 2 3 3 3

DM BH Citi 3 5 2 2 2

PKO BP 4 4 4 6 4

BZ WBK 5 3 11 11 7

ING 6 6 5 8 8

UniCredit 7 7 6 4 9

Wood&Co 8 9 12 9 14

IDM 9 8 13 13 6

DM Trigon 10 13 15 10 5

Equity Research ranking - 2013

Bank 2013 2012

DM BZ WBK 1 4

mBank 3 3

Espirito Santo 4 11

PKO BP 5 6

Best financial sector

analyst

2012

Best financial sector

analyst

2013

7

IPOPEMA TFI and IPOPEMA Asset Management

IPOPEMA Investment Fund Consistently among the best investment funds in Poland

IPOPEMA Asset Management One of the fastest growing asset management funds

IPOPEMA fund performance

IPOPEMA TFI focuses mainly on the closed investment funds (FIZ), dedicated

to affluent consumers (High Net Worth Individuals).

It currently manages 95 funds with PLN 25,4 bn of assets under management

(31/08/2014).

The leading asset management team in the equity, fixed-income and real

estate groups.

Service of active management through the funds (IPOPEMA Opportunity FIZ,

IPOPEMA Global Macro FIZ, IPOPEMA Global Macro EUR FIZ, Total FIZ).

Offer of the open-end investment funds: IPOPEMA SFIO, m-INDEKS FIO.

Valuation on 29/08/2014

IPOPEMA Asset Management provides investment management

services dedicated to wealthy clients, who require specialized

financial advisory support in managing their finances.

The minimum contribution necessary to be eligible for Asset

Management services is PLN 4m.

Among the company’s clients are institutions such as insurance

companies, mutual funds, non-profit organizations and also

individual investors.

A broad range of investment strategies: both active and passive

based on an unique concept of investing across the business

cycle.

The value of assets managed by IPOPEMA AM is PLN 1,8 bn

(31/08/2014).

Fund change 3M change 12M

IPOPEMA Gotówkowy 0,80% 3,70%

IPOPEMA Obligacji 0,30% 5,40%

IPOPEMA Makro Alokacji -2,50% -0,50%

IPOPEMA Mały ch i Średnich Spółek -6,10% -3,50%

IPOPEMA Agresy wny -2,60% -5,20%

IPOPEMA Short Equity -0,92% -6,64%

IPOPEMA m-INDEKS FIO -1,70% 10,40%

Fund managing team

Krzysztof Cesarz, CFA Michał Rabiej, CFA, CIIA Łukasz Jakubowski, CFA Bogusław Stefaniak

8

IPOPEMA - strong in Investment Banking

The largest Capital Markets transactions (2010-2014)

9

IPOPEMA - strong in Investment Banking

Selected Capital Markets transactions

10

IPOPEMA - strong in Investment Banking

Issue agent and depository

of bonds

57,000,000 PLN

April 2010

Selected Debt transactions

Selected Private Equity, M&A and other transactions

Private offering of bonds

11

IPOPEMA Securities on the Warsaw Stock Exchange

IPOPEMA Securities share price May 2009 – August 2014

Source: WSE, IPOPEMA

IPO on WSE on 26th May 2009

Private placement dedicated to institutional investors

Current market cap amounts to PLN 150-250 mn

IPO price = 5 PLN

IPOPEMA Securities Shareholders

Entities related to IPOPEMA

45,6%

OFE PZU 9,9%

Quercus TFI 5,9%

free float 38,7%

0

2

4

6

8

10

12

14

16

18

20

12

IPOPEMA Business Consulting

Strategy,

Organisation

and Managment

Business strategy,

new operating

models

Optimisation of

business

processes and

organisational

structures

Cost reduction and

employment

optimisation

Cash flow

improvement

Business plans and

feasibility studies

Mergers and

Acquisitions

Market research

Integration

strategies

Synergy

assessment and

development of

integration

programmes

Process and

organisational

transformation

Programme

Management

(PMO)

Shared

Services and

Outsourcing

Back office

reorganisation

strategy

Efficiency

assessment and

optimisation of

back office

functions based on

benchmarking

analysis

Comprehensive

implementation of

shared services

centres

Preparation for

outsourcing

Interim

management

Supply Chain

Optimisation

Logistics and

operational audits,

the SCM maturity

profiles

Optimisation of

business

processes in the

area of logistics,

production,

procurement and

sales,

improvement of

efficiency and

productivity

Integrated

operational

planning S&OP

Design and

implementation of

advanced planning

systems APS

IT Management

and

Technologies

IT strategy and

organisation

IT optimisation,

support and

development

Management of IT

projects

Solutions for

management of

processes and

electronic

document

circulation

(scanning, OCR,

workflow)

Business

Intelligence

SAP

Applications

Defining

requirements and

support in bidding

processes

Implementation of

SAP applications

Sector specific

solutions

Post

implementation

audits

Optimisation and

improvement of

implemented SAP

solutions

Procurement

Optimisation

Procurement audits

(to check if the

procedures in

place are effective)

Sourcing (cost

optimisation)

Procurement

organisation

(centralisation and

implementation of

IT tools)

Process

optimisation

Development of

market specific

procurement

strategies

13

IPOPEMA’s Foreign Partners – in the Merger Alliance

IPOPEMA Securities is the exclusive Polish partner of Mergers Alliance, an international network of corporate

finance and investment banking firms.

Partner firms of Mergers Alliance specialise in mid-sized M&A deals.

Mergers Alliance is an organisation with professionals based in 48 locations.

14

14

• IPOPEMA Securities S.A. (the “Company”, “IPOPEMA”) with registered office in Warsaw, is a licensed brokerage house operating on the basis of the license issued by the Polish Securities and Exchange

Commission (presently the Polish Financial Supervision Authority) dated 30 June 2005. The Company is entered in the National Court Register maintained by the District Court for the Capital City of Warsaw,

12th Commercial Division of the National Court Register, under number KRS 0000230737. NIP (tax identification number): 527-24-68-122. Share capital: PLN 2.993.783,60 paid up in full. The Company is

supervised by the Polish Financial Supervision Authority.

• This presentation (“Presentation”) has been prepared solely for use by its customers and shareholders or analysts. The information and data contained herein may not constitute the basis for an investment

decision. They should not be treated as an offer to purchase securities, an offer, invitation or solicitation of an offer to purchase, invest or make any transactions involving such securities or recommendation

to conclude any transaction, in particular in respect of securities of the Company or form of investment advice, as well as offer to conclude an agreement within the meaning of the Civil Code.

• The Company declares that it makes every effort to ensure that this Presentation has been prepared with due care. All information contained herein are derived from the Company's own sources or external

sources deemed by the Company to be reliable, but there is no guarantee that they are complete and fully reflect the facts. The Company cannot guarantee the correctness and completeness of the information

contained herein and accepts no responsibility for damages resulting from its use for any other purpose. The Company shall not be liable for the consequences of decisions taken on the basis of the

Presentation and opinion contained herein. All opinions and assessments contained in this Presentation are an expression of our best knowledge, supported by market information from competent sources,

applicable at the time of its preparation. In no event may the content of this Presentation be construed as any type of explicit or implicit representation or warranty made by the Company or its representatives.

The information contained in this Presentation has not been independently verified and may be subject to change at any time without prior notice.

• Publishing by IPOPEMA of data contained in this Presentation does not constitute an infringement of the laws applicable to companies whose shares are traded on a regulated market, in particular on the

regulated market operated by the Warsaw Stock Exchange S.A. Information contained herein has been communicated to the public by IPOPEMA within current or periodic reports, or complement them, not

giving the basis to pass them as a part of fulfilling by IPOPEMA disclosure obligations of a public company. The only source of reliable data describing IPOPEMA’s financial results, forecasts, events or

indicators are current or periodic reports submitted by IPOPEMA in satisfaction of its disclosure obligation under Polish law.

• This Presentation is not for release, directly or indirectly, in or into the United States, Australia, Canada or Japan.

Disclaimer

IPOPEMA Securities S.A.

Ul. Próżna 9, 00-107 Warsaw, Poland

Tel. /+48 22/ 236 92 00, fax /+48 22/ 236 92 82

E-mail: [email protected]

www.ipopema.pl